Euro-Med Laboratories Phil., Inc. (PSE: EURO)

EURO Balance Sheet

Financials in millions PHP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,001	881.35	615.72	554.5	508.42	1,096
Trading Asset Securities	202.01	202.01	190.6	173.39	224.03	252.15
Cash & Short-Term Investments	1,203	1,083	806.31	727.89	732.44	1,348
Cash Growth	51.46%	34.36%	10.77%	-0.62%	-45.66%	1.00%
Accounts Receivable	1,742	1,592	1,439	1,319	1,537	1,749
Other Receivables	60.28	111.52	43.87	44.07	38.84	34.49
Receivables	1,802	1,703	1,483	1,363	1,584	1,802
Inventory	1,774	1,693	1,537	1,264	1,396	1,165
Prepaid Expenses	333.32	321.84	317.88	296.64	335.8	217.92
Other Current Assets	225.06	334.27	283.44	259.4	263.87	256.97
Total Current Assets	5,338	5,135	4,428	3,911	4,312	4,790
Property, Plant & Equipment	4,893	4,961	4,961	5,052	4,986	4,769
Long-Term Investments	0.2	0.2	0.2	0.2	0.2	0.2
Other Intangible Assets	268.13	268.13	268.13	268.21	268.39	268.57
Long-Term Deferred Tax Assets	110.9	109.15	97.15	105.95	125.32	91.65
Long-Term Deferred Charges	14.61	21.07	38.79	51.44	84.36	130.2
Other Long-Term Assets	281.47	268.76	266.17	302.82	295.49	288.55
Total Assets	10,906	10,764	10,059	9,691	10,072	10,338
Accounts Payable	268.87	477.38	345.59	301.14	529.84	476.28
Accrued Expenses	99.71	104.6	69.31	85.39	192.46	168.3
Short-Term Debt	3,355	3,014	2,633	2,283	2,642	2,296
Current Portion of Long-Term Debt	112.71	209.75	184.3	195.08	353.63	482.57
Current Portion of Leases	55.37	58.6	60.82	49.18	37.78	36.77
Current Income Taxes Payable	22.78	51.64	31.18	22.8	56.98	93.84
Current Unearned Revenue	19.92	1.81	0.75	0.4	0.39	0.91
Other Current Liabilities	0.22	0.11	0.62	0.6	20.11	22.36
Total Current Liabilities	3,935	3,918	3,326	2,937	3,833	3,577
Long-Term Debt	682.71	666.91	663.62	788.75	459.89	994.85
Long-Term Leases	86.86	89.48	138.91	105.29	97.87	113.93
Other Long-Term Liabilities	0	-	-	-	-	-
Total Liabilities	4,949	4,919	4,350	4,051	4,624	4,882
Common Stock	4,112	4,112	4,112	4,112	4,112	4,112
Additional Paid-In Capital	66.61	66.61	66.61	66.61	66.61	66.61
Retained Earnings	1,804	1,692	1,547	1,494	1,325	1,320
Comprensive Income & Other	-25.15	-25.15	-16.52	-31.79	-55.6	-42.74
Shareholders' Equity	5,957	5,845	5,709	5,641	5,448	5,456
Total Liabilities & Equity	10,906	10,764	10,059	9,691	10,072	10,338
Total Debt	4,293	4,039	3,681	3,421	3,591	3,925
Net Cash (Debt)	-3,090	-2,956	-2,874	-2,693	-2,859	-2,577
Net Cash Per Share	-0.75	-0.72	-0.70	-0.65	-0.70	-0.63
Filing Date Shares Outstanding	4,112	4,112	4,112	4,112	4,112	4,112
Total Common Shares Outstanding	4,112	4,112	4,112	4,112	4,112	4,112
Working Capital	1,402	1,217	1,102	973.51	478.59	1,213
Book Value Per Share	1.45	1.42	1.39	1.37	1.32	1.33
Tangible Book Value	5,689	5,577	5,441	5,372	5,179	5,188
Tangible Book Value Per Share	1.38	1.36	1.32	1.31	1.26	1.26
Land	173.34	173.34	131.83	106.59	106.59	106.59
Buildings	2,991	2,981	2,816	2,777	2,552	2,351
Machinery	6,427	6,365	6,278	6,254	6,193	5,944

Source: S&P Capital IQ. Standard template. Financial Sources.